Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4405 ARTÍCULOS , VIENDO DEL 3916 AL 3930

Anhedonia and its correlation with clinical aspects in Parkinson's disease

Nagayama H, Maeda T, Uchiyama T, Hashimoto M, Nomoto N, Kano O, Takahashi T, Terashi H, Hamada S, Hasegawa T, Hatano T, Takahashi T, Baba Y, Sengoku R, Watanabe H, Inoue M, Kadowaki T, Kaneko S, Shimura H, Kubo SI; Young Japanese Expert Group for Parkinson's Disease and Movement Disorders: YJ-EXPANDS.

J Neurol Sci. 2017 Jan 15;372:403-407. doi: 10.1016/j.jns.2016.10.051. Epub 2016 Nov 3.

Association of plasma homocysteine, vitamin B12 and folate levels with cognitive function in Parkinson's disease: A meta-analysis

Xie Y, Feng H, Peng S, Xiao J, Zhang J.

Neurosci Lett. 2017 Jan 1;636:190-195. doi: 10.1016/j.neulet.2016.11.007. Epub 2016 Nov 10.

Treatments and compositions targeting α-synuclein: a patent review (2010-2016)

Jęśko H, Lenkiewicz AM, Adamczyk A.

Expert Opin Ther Pat. 2017 Apr;27(4):427-438. doi: 10.1080/13543776.2017.1261112. Epub 2016 Nov 23.

Capgras syndrome in Parkinson's disease: two new cases and literature review

Cannas A, Meloni M, Mascia MM, Solla P, Cocco L, Muroni A, Floris G, Di Stefano F, Marrosu F.

Neurol Sci. 2017 Feb;38(2):225-231. doi: 10.1007/s10072-016-2765-9. Epub 2016 Nov 15.

Advanced magnetic resonance imaging of neurodegenerative diseases

Agosta F, Galantucci S, Filippi M.

Neurol Sci. 2017 Jan;38(1):41-51. doi: 10.1007/s10072-016-2764-x. Epub 2016 Nov 15.

Sirtuin 5: a review of structure, known inhibitors and clues for developing new inhibitors

Yang L, Ma X, He Y, Yuan C, Chen Q, Li G, Chen X.

Sci China Life Sci. 2017 Mar;60(3):249-256. doi: 10.1007/s11427-016-0060-7. Epub 2016 Nov 17.

Chronic electrocorticography for sensing movement intention and closed-loop deep brain stimulation with wearable sensors in an essential tremor patient

Herron JA, Thompson MC, Brown T, Chizeck HJ, Ojemann JG, Ko AL.

J Neurosurg. 2017 Sep;127(3):580-587. doi: 10.3171/2016.8.JNS16536. Epub 2016 Nov 18.

Sixty-hertz stimulation improves bradykinesia and amplifies subthalamic low-frequency oscillations

Blumenfeld Z, Koop MM, Prieto TE, Shreve LA, Velisar A, Quinn EJ, Trager MH, Brontë-Stewart H.

Mov Disord. 2017 Jan;32(1):80-88. doi: 10.1002/mds.26837. Epub 2016 Nov 8.

Alterations of the circadian system in Parkinson's disease patients

Fifel K.

Mov Disord. 2017 May;32(5):682-692. doi: 10.1002/mds.26865. Epub 2016 Nov 15.

Rapidly progressive primary progressive aphasia and parkinsonism with novel GRN mutation

Galimberti D, Cioffi SM, Fenoglio C, Serpente M, Oblak AL, Rodriguez-Porcel F, Oldoni E, Hagen MC, Arcaro M, Scarpini E, Ghetti B, Espay AJ.

Mov Disord. 2017 Mar;32(3):476-478. doi: 10.1002/mds.26872. Epub 2016 Nov 15.

l-DOPA-induced dyskinesia and neuroinflammation: do microglia and astrocytes play a role?

Carta AR, Mulas G, Bortolanza M, Duarte T, Pillai E, Fisone G, Vozari RR, Del-Bel E.

Eur J Neurosci. 2017 Jan;45(1):73-91. doi: 10.1111/ejn.13482. Epub 2016 Dec 9.

Spinal cord stimulation improves gait in patients with Parkinson's disease previously treated with deep brain stimulation

Pinto de Souza C, Hamani C, Oliveira Souza C, Lopez Contreras WO, Dos Santos Ghilardi MG, Cury RG, Reis Barbosa E, Jacobsen Teixeira M, Talamoni Fonoff E.

Mov Disord. 2017 Feb;32(2):278-282. doi: 10.1002/mds.26850. Epub 2016 Nov 10.

Molecular Imaging and Precision Medicine in Dementia and Movement Disorders

Mallik AK, Drzezga A, Minoshima S.

PET Clin. 2017 Jan;12(1):119-136. doi: 10.1016/j.cpet.2016.08.003. Epub 2016 Oct 5.

A Systematic Review of Voice Therapy: What "Effectiveness" Really Implies

Desjardins M, Halstead L, Cooke M, Bonilha HS.

J Voice. 2017 May;31(3):392.e13-392.e32. doi: 10.1016/j.jvoice.2016.10.002. Epub 2016 Nov 15.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias